Compugen to Participate in the JMP Securities Hematology and Oncology Summit
- Tuesday, November 29, 2022, 7:15
- Environment
- Add a comment
HOLON, Israel, Nov. 29, 2022 /PRNewswire/ — Compugen Ltd. (NASDAQ: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today that Anat Cohen-Dayag, Ph.D., President and CEO, and additional members of its management team will…
About the Author
adminasapcorp has written 41523 stories on this site.